335 related articles for article (PubMed ID: 33763494)
1. Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19.
In 't Veld AE; Jansen MAA; Ciere LCA; Moerland M
J Immunol Res; 2021; 2021():6659410. PubMed ID: 33763494
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models.
Rosenke K; Jarvis MA; Feldmann F; Schwarz B; Okumura A; Lovaglio J; Saturday G; Hanley PW; Meade-White K; Williamson BN; Hansen F; Perez-Perez L; Leventhal S; Tang-Huau TL; Callison J; Haddock E; Stromberg KA; Scott D; Sewell G; Bosio CM; Hawman D; de Wit E; Feldmann H
JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33090972
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease.
Mallat J; Hamed F; Balkis M; Mohamed MA; Mooty M; Malik A; Nusair A; Bonilla MF
Medicine (Baltimore); 2020 Dec; 99(52):e23720. PubMed ID: 33350752
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
Shah S; Das S; Jain A; Misra DP; Negi VS
Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.
Barratt-Due A; Olsen IC; Nezvalova-Henriksen K; Kåsine T; Lund-Johansen F; Hoel H; Holten AR; Tveita A; Mathiessen A; Haugli M; Eiken R; Kildal AB; Berg Å; Johannessen A; Heggelund L; Dahl TB; Skåra KH; Mielnik P; Le LAK; Thoresen L; Ernst G; Hoff DAL; Skudal H; Kittang BR; Olsen RB; Tholin B; Ystrøm CM; Skei NV; Tran T; Dudman S; Andersen JT; Hannula R; Dalgard O; Finbråten AK; Tonby K; Blomberg B; Aballi S; Fladeby C; Steffensen A; Müller F; Dyrhol-Riise AM; Trøseid M; Aukrust P;
Ann Intern Med; 2021 Sep; 174(9):1261-1269. PubMed ID: 34251903
[TBL] [Abstract][Full Text] [Related]
8. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
[TBL] [Abstract][Full Text] [Related]
10. Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists.
Bosquet A; Affo C; Plaisance L; Poenou G; Mortier E; Mahé I
PLoS One; 2022; 17(1):e0261843. PubMed ID: 35061735
[TBL] [Abstract][Full Text] [Related]
11. What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.
Altulea D; Maassen S; Baranov MV; van den Bogaart G
J Mol Cell Biol; 2021 Jul; 13(3):175-184. PubMed ID: 33693723
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine (HCQ): real treatment or false hope?
El Bakkouri K
Int J Antimicrob Agents; 2021 Jan; 57(1):106170. PubMed ID: 33408023
[No Abstract] [Full Text] [Related]
13. No benefit of hydroxychloroquine on SARS-CoV-2 viral load reduction in non-critical hospitalized patients with COVID-19.
Faíco-Filho KS; Conte DD; de Souza Luna LK; Carvalho JMA; Perosa AHS; Bellei N
Braz J Microbiol; 2020 Dec; 51(4):1765-1769. PubMed ID: 33111169
[TBL] [Abstract][Full Text] [Related]
14. Review on the Clinical Pharmacology of Hydroxychloroquine Sulfate for the Treatment of COVID-19.
Cui C; Tu S; En VSJ; Li X; Yao X; Li H; Liu D
Curr Drug Metab; 2020; 21(6):427-435. PubMed ID: 32520683
[TBL] [Abstract][Full Text] [Related]
15. An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia.
Purwati ; Miatmoko A; Nasronudin ; Hendrianto E; Karsari D; Dinaryanti A; Ertanti N; Ihsan IS; Purnama DS; Asmarawati TP; Marfiani E; Yulistiani ; Rosyid AN; Wulaningrum PA; Setiawan HW; Siswanto I; Tri Puspaningsih NN
PLoS One; 2021; 16(6):e0252302. PubMed ID: 34143818
[TBL] [Abstract][Full Text] [Related]
16. Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing.
Garcia-Cremades M; Solans BP; Hughes E; Ernest JP; Wallender E; Aweeka F; Luetkemeyer AF; Savic RM
Clin Pharmacol Ther; 2020 Aug; 108(2):253-263. PubMed ID: 32285930
[TBL] [Abstract][Full Text] [Related]
17. [Lack of clinical evidence for the use of hydroxychloroquine to treat SARS-CoV-2 infection].
Troldborg A; Bartels LE; Deleuran B
Ugeskr Laeger; 2020 May; 182(20):. PubMed ID: 32400380
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis.
Zang Y; Han X; He M; Shi J; Li Y
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):775-782. PubMed ID: 32892293
[TBL] [Abstract][Full Text] [Related]
19. Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics.
Liu WD; Chang SY; Lan TY; Lin YC; Kao JH; Liao CH; Tsai MJ; Kuo PH; Huang YS; Wang JT; Sheng WH; Hsieh SC; Chiang BL; Chen YC; Chang SC
J Formos Med Assoc; 2021 May; 120(5):1269-1273. PubMed ID: 32888840
[TBL] [Abstract][Full Text] [Related]
20. Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19.
Al-Bari AA
Curr Drug Targets; 2020; 21(16):1703-1721. PubMed ID: 32552642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
